...
A trial of the drug fialuridine (FIAU) on hepatitis sufferers has been stopped after several died and others became seriously ill. ...
The Food and Drug Administration, the American drug regulator, is set to tighten controls on the safety of drugs so that adverse reactions can be identified more quickly. ...